Anticoagulant prescribing trends, bleeding events, and reversal agent use in pediatric patients: A retrospective, real-world study

• Sofia D’Abrantes,

  Roles Conceptualization, Formal analysis, Investigation, Methodology, Writing – original draft, Writing – review & editing

  Affiliation Data Sciences and Artificial Intelligence, R&D BioPharmaceuticals, AstraZeneca, Cambridge Biomedical Campus, Cambridge, United Kingdom

  https://orcid.org/0000-0002-1367-2944

  ⨯
• Christoph Male,

  Roles Conceptualization, Investigation, Methodology, Writing – original draft, Writing – review & editing

  Affiliation Department of Pediatrics, Medical University of Vienna, Vienna, Austria

  https://orcid.org/0000-0002-4989-6421

  ⨯
• Nick Brown,

  Roles Conceptualization, Investigation, Methodology, Writing – original draft, Writing – review & editing

  Affiliations Department of Women’s and Children’s Health, International Maternal and Child Health (IMCH), Uppsala University, Uppsala, Sweden, Department of Paediatrics, Länssjukhuset Gävle-Sandviken, Gävle, Sweden, Department of Child Health, Aga Khan University, Karachi, Pakistan

  ⨯
• Mikael Bjursell,

  Roles Conceptualization, Investigation, Methodology, Writing – original draft, Writing – review & editing

  Affiliation Late-stage Development, Cardiovascular, Renal and Metabolism, R&D BioPharmaceuticals, AstraZeneca, Gothenburg, Sweden

  ⨯
• Philip Ambery,

  Roles Conceptualization, Investigation, Methodology, Writing – original draft, Writing – review & editing

  Affiliation Late-stage Development, Cardiovascular, Renal and Metabolism, R&D BioPharmaceuticals, AstraZeneca, Gothenburg, Sweden

  ⨯
• Anders Berggren,

  Roles Conceptualization, Investigation, Methodology, Writing – original draft, Writing – review & editing

  Affiliation Late-stage Development, Cardiovascular, Renal and Metabolism, R&D BioPharmaceuticals, AstraZeneca, Gothenburg, Sweden

  ⨯
• Ulrika Mattsson

  Roles Conceptualization, Investigation, Methodology, Writing – original draft, Writing – review & editing

  * E-mail: ulrika.mattsson1@astrazeneca.com

  Affiliation Late-stage Development, Cardiovascular, Renal and Metabolism, R&D BioPharmaceuticals, AstraZeneca, Gothenburg, Sweden

  https://orcid.org/0009-0000-8422-6071

  ⨯